Skip to main content
Premium Trial:

Request an Annual Quote

BioSpin Buy Boosts Bruker BioSciences' Shares Nearly 20 Percent

NEW YORK (GenomeWeb News) - Bruker BioSciences’ shares bolted up 19.5 percent today following this morning’s announcement that it is buying its affiliate Bruker BioSpin for $914 million in cash and stock.
 
In afternoon trading, Bruker’s shares had risen $1.87 to $11.16.
 
Bruker BioSpin makes magnetic resonance core technology. It posted $447 million in revenue and $56.6 million in net income in 2006.
 
The combined firm expects to have 2007 pro forma revenue of more than $900 million.
The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.